drugset / Trial / NCT06560333
iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The present study aims to evaluate the efficacy and safety of different combinations of oral antidiabetics in patients with inadequate glycemic control on metformin monotherapy.
Timeline
- Start
- 2026-11-30
- Primary completion
- 2027-04-30
- Completion
- 2029-02-28
Outcome
Outcome not reported
Stopped (Business): “Strategic change in development priorities”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Forxiga | Unknown | 10 mg | Oral |
| Comparator | Sitagliptin | Small molecule | 100 mg | Oral |
| Comparator | Glifage XR | Unknown | 1000 mg | Oral |